Lincoln Pharmaceuticals Ltd (LINCOLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 294056, "name": "Lincoln Pharma.", "stock_name": "Lincoln Pharma.", "full_name": "Lincoln Pharmaceuticals Ltd", "name_url": "stocks-analysis/lincoln-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "615.00", "chg": 21.15, "chgp": "3.56%", "dir": 1, "prev_price": "593.85", "mcapval": "1,180.00 Cr", "mcap": "Micro Cap", "scripcode": 531633, "symbol": "LINCOLN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE405C01035", "curr_date": "Apr 02", "curr_time": "", "bse_nse_vol": "49.33 k", "exc_status": "Active", "traded_date": "Apr 02, 2026", "traded_date_str": "2026 04 02", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Lincoln Pharmaceuticals Ltd’s Mildly Bullish Shift: 0.36% Weekly Dip Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltds-mildly-bullish-shift-036-weekly-dip-amid-mixed-signals-3922960", "imagepath": "", "date": "2026-03-29 13:00:48", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 16:</strong> Golden Cross formation signals potential bullish breakout</p>\n <p><strong>Mar 17:</strong> Mojo Grade upgraded to Hold on technical and valuation improvements</p>\n <p><strong>Mar 17:</strong> Technical momentum shifts to mildly bullish amid mixed indicators</p>\n <p><strong>Mar 20:</strong> Week closes at Rs.601.30 (-0.36%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.603.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=..." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-3921525", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LincolnPharmace_mojoScore_3921525.png", "date": "2026-03-28 10:10:03", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Lincoln Pharmaceuticals Ltd Upgraded to Hold on Technical and Valuation Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-upgraded-to-hold-on-technical-and-valuation-improvements-3895839", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LincolnPharmace_mojoScore_3895839.png", "date": "2026-03-17 08:09:37", "description": "Lincoln Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite some challenges in recent quarterly performance. The upgrade, effective from 16 March 2026, is underpinned by a shift in technical sentiment and a fair valuation stance amid a micro-cap pharmaceutical sector backdrop." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicators-3895572", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LincolnPharmace_technicaldot_3895572.png", "date": "2026-03-17 08:00:57", "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook on weekly charts, despite a recent day decline of 3.87%. This nuanced change is reflected across key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, signalling a complex but cautiously optimistic scenario for investors in this micro-cap pharmaceutical stock." }, { "title": "Lincoln Pharmaceuticals Ltd Forms Golden Cross, Signalling Potential Bullish Breakout", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3894774", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LincolnPharmace_goldencross_3894774.png", "date": "2026-03-16 18:00:08", "description": "Lincoln Pharmaceuticals Ltd has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average (DMA) crosses above the 200-DMA. This development often signals a potential bullish breakout, indicating a shift in long-term momentum and a possible trend reversal in the stock’s price trajectory." }, { "title": "Why is Lincoln Pharmaceuticals Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lincoln-pharmaceuticals-ltd-fallingrising-3890357", "imagepath": "", "date": "2026-03-14 01:13:35", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>On 13 March, Lincoln Pharmaceuticals witnessed a notable dip, falling ₹13.95 or 2.26% to close at ₹603.45. This decline forms part of a three-day losing streak during which the stock has shed approximately 4.4% of its value. Intraday, the share price touched a low of ₹596.40, marking a 3.4% drop from recent highs. While the stock remains above its 50-day, 100-day, and 200-day moving averages, it is currently trading below its 5-day and 20-day averages, signalling some short-term weakness.</p>\n<p>Despite this recent underperformance, Lincoln Pharmaceuticals has outperformed broader benchmarks over multiple time horizons. Year-to-date, the stock has surged 24.89%, significantly outpacing the Sensex’s decline of 12.50%. Over one year, it ..." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3878904", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LincolnPharmace_mojoScore_3878904.png", "date": "2026-03-09 10:10:36", "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3878888", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LincolnPharmace_mojoScore_3878888.png", "date": "2026-03-08 10:10:26", "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3868106", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LincolnPharmace_technicaldot_3868106.png", "date": "2026-03-04 08:01:38", "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite this, the stock continues to demonstrate pockets of bullishness in key weekly indicators, presenting a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector." } ], "total": 959, "sid": "294056", "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "25-Mar-2026", "details": "Intimation of Closure of Trading Window.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "23-Feb-2026", "details": "Pursuant to Regulation of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we attach herewith transcript of conference call held on February 18 2026. A copy of the same is available on website of the company.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "18-Feb-2026", "details": "We wish to inform you that the Company participated in investor conference- Call Conference on February 18 2026. No Unpublished Price Sensitive Information (UPSI) was shared / discussed in the meeting with investors.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09", "dt": "2009-03-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 16: Golden Cross formation signals potential bullish breakout

Mar 17: Mojo Grade upgraded to Hold on technical and valuation improvements

Mar 17: Technical momentum shifts to mildly bullish amid mixed indicators

Mar 20: Week closes at Rs.601.30 (-0.36%)

Week Open

Rs.603.45

Week Close

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-03-28 10:10:03

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Lincoln Pharmaceuticals Ltd Upgraded to Hold on Technical and Valuation Improvements

2026-03-17 08:09:37

Lincoln Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite some challenges in recent quarterly performance. The upgrade, effective from 16 March 2026, is underpinned by a shift in technical sentiment and a fair valuation stance amid a micro-cap pharmaceutical sector backdrop.

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators

2026-03-17 08:00:57

Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook on weekly charts, despite a recent day decline of 3.87%. This nuanced change is reflected across key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, signalling a complex but cautiously optimistic scenario for investors in this micro-cap pharmaceutical stock.

Read full news article

Lincoln Pharmaceuticals Ltd Forms Golden Cross, Signalling Potential Bullish Breakout

2026-03-16 18:00:08

Lincoln Pharmaceuticals Ltd has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average (DMA) crosses above the 200-DMA. This development often signals a potential bullish breakout, indicating a shift in long-term momentum and a possible trend reversal in the stock’s price trajectory.

Read full news article

Why is Lincoln Pharmaceuticals Ltd falling/rising?

2026-03-14 01:13:35

Recent Price Movement and Market Context

On 13 March, Lincoln Pharmaceuticals witnessed a notable dip, falling ₹13.95 or 2.26% to close at ₹603.45. This decline forms part of a three-day losing streak during which the stock has shed approximately 4.4% of its value. Intraday, the share price touched a low of ₹596.40, marking a 3.4% drop from recent highs. While the stock remains above its 50-day, 100-day, and 200-day moving averages, it is currently trading below its 5-day and 20-day averages, signalling some short-term weakness.

Despite this recent underperformance, Lincoln Pharmaceuticals has outperformed broader benchmarks over multiple time horizons. Year-to-date, the stock has surged 24.89%, significantly outpacing the Sensex’s decline of 12.50%. Over one year, it ...

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-03-09 10:10:36

Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-03-08 10:10:26

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-04 08:01:38

Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite this, the stock continues to demonstrate pockets of bullishness in key weekly indicators, presenting a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News